Anzeige
+++>>> Der Kampf um Uran hat begonnen: Woher sollen die nächsten Milliarden Pfund kommen? <<<+++
PortfolioPlus
Portfolio-Tracker – Kurse, Renditeanalyse und Dividendenplaner an einem Ort.
Anzeige
EQS-News

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces 29.08.2026, 04:05 Uhr von EQS News Jetzt kommentieren: 0

EQS-News: INTCO Medical / Key word(s): Sales Result/Annual Results
INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces

29.08.2026 / 04:05 CET/CEST
The issuer is solely responsible for the content of this announcement.


ZIBO, China, Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year earlier. Net profit attributable to shareholders rose 17.86% to RMB 837.3 million (approx. US$124.6 million). Adjusted net profit attributable to shareholders, excluding nonrecurring gains and losses, climbed 165.00% to RMB 1.06 billion (approx. US$157.7 million).

By the end of the reporting period, INTCO Medical's annualized production capacity for disposable gloves had reached 107 billion pieces. The total comprised 74 billion disposable nitrile gloves and 33 billion disposable vinyl gloves. This scale reinforces the Company's position as the world's largest producer of disposable gloves.

INTCO Medical's integrated value chain extends from nitrile latex and the research, development and manufacturing of core production equipment to glove production and global sales. Through nitrile latex manufacturers in which it holds controlling or equity interests, the Company strengthens raw material supply security, helping mitigate the impact of international crude oil price fluctuations on key raw material costs while enhancing supply stability and cost efficiency. Its coordinated domestic and international production capacity enables the Company to allocate manufacturing resources according to market demand, respond efficiently to customer needs and support reliable delivery across global markets. Together, these capabilities strengthen operational resilience.

During the reporting period, R&D expenses rose 20.62% to RMB 245.9 million (approx. US$36.6 million). The Company continued to develop high-performance products, including Syntex™ Synthetic Latex Gloves, a proprietary glove that does not contain natural latex proteins and offers high elasticity and puncture resistance, and Synmax Pro Exam Gloves, an enhanced vinyl glove for food service and industrial applications. The Company has also introduced safety work gloves, household gloves and other products to meet diverse application needs.

Smart manufacturing boosts efficiency and quality. INTCO Medical's latest nitrile glove production line spans more than 1.6 kilometers and incorporates about 500 control points. Its precision distributed control system automatically manages temperature and liquid levels based on production conditions, helping reduce labor and energy consumption while maintaining stable output. The Company's glove product yield remained above 99% during the reporting period.

INTCO Medical will continue optimizing global capacity and advancing protective product innovation to support growth.

Cision View original content:https://www.prnewswire.co.uk/news-releases/intco-medical-reports-40-6-h1-2026-revenue-growth-expands-worlds-largest-disposable-glove-capacity-to-107-billion-pieces-302863234.html

rt.gif?NewsItemId=EN35940&Transmission_Id=202608282158PR_NEWS_EURO_ND__EN35940&DateId=20260828


29.08.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


2390642  29.08.2026 CET/CEST

Kommentare (0) ... diskutiere mit.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
k.A. k.A. k.A. k.A.
Schreib den ersten Kommentar!

Dis­clai­mer: Die hier an­ge­bo­te­nen Bei­trä­ge die­nen aus­schließ­lich der In­for­ma­t­ion und stel­len kei­ne Kauf- bzw. Ver­kaufs­em­pfeh­lung­en dar. Sie sind we­der ex­pli­zit noch im­pli­zit als Zu­sich­er­ung ei­ner be­stim­mt­en Kurs­ent­wick­lung der ge­nan­nt­en Fi­nanz­in­stru­men­te oder als Handl­ungs­auf­for­der­ung zu ver­steh­en. Der Er­werb von Wert­pa­pier­en birgt Ri­si­ken, die zum To­tal­ver­lust des ein­ge­setz­ten Ka­pi­tals füh­ren kön­nen. Die In­for­ma­tion­en er­setz­en kei­ne, auf die in­di­vi­du­el­len Be­dür­fnis­se aus­ge­rich­te­te, fach­kun­di­ge An­la­ge­be­ra­tung. Ei­ne Haf­tung oder Ga­ran­tie für die Ak­tu­ali­tät, Rich­tig­keit, An­ge­mes­sen­heit und Vol­lständ­ig­keit der zur Ver­fü­gung ge­stel­lt­en In­for­ma­tion­en so­wie für Ver­mö­gens­schä­den wird we­der aus­drück­lich noch stil­lschwei­gend über­nom­men. Die Mar­kets In­side Me­dia GmbH hat auf die ver­öf­fent­lich­ten In­hal­te kei­ner­lei Ein­fluss und vor Ver­öf­fent­lich­ung der Bei­trä­ge kei­ne Ken­nt­nis über In­halt und Ge­gen­stand die­ser. Die Ver­öf­fent­lich­ung der na­ment­lich ge­kenn­zeich­net­en Bei­trä­ge er­folgt ei­gen­ver­ant­wort­lich durch Au­tor­en wie z.B. Gast­kom­men­ta­tor­en, Nach­richt­en­ag­en­tur­en, Un­ter­neh­men. In­fol­ge­des­sen kön­nen die In­hal­te der Bei­trä­ge auch nicht von An­la­ge­in­te­res­sen der Mar­kets In­side Me­dia GmbH und/oder sei­nen Mit­ar­bei­tern oder Or­ga­nen be­stim­mt sein. Die Gast­kom­men­ta­tor­en, Nach­rich­ten­ag­en­tur­en, Un­ter­neh­men ge­hör­en nicht der Re­dak­tion der Mar­kets In­side Me­dia GmbH an. Ihre Mei­nung­en spie­geln nicht not­wen­di­ger­wei­se die Mei­nung­en und Auf­fas­sung­en der Mar­kets In­side Me­dia GmbH und de­ren Mit­ar­bei­ter wie­der. Aus­führ­lich­er Dis­clai­mer